Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jason P. Rhodes currently holds 60,000 shares of Replimune Group, Inc. (REPL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason P. Rhodes has been a net seller of REPL stock. They have purchased $25.0M and sold $86.5M worth of shares.
Jason P. Rhodes's most recent insider trade was on Jun 6, 2024, when they sold 60,000 shares at $0.00 per share.
Jason P. Rhodes serves as Executive at Replimune Group, Inc. (REPL). They have executed 180 insider transactions totaling $111.5M over their tenure at the company.
Jason P. Rhodes holds the position of Executive at Replimune Group, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Jason P. Rhodes has shown a selling trading pattern, with $25.0M in total purchases and $86.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jason P. Rhodes was on Dec 12, 2022, when they purchased $10.0M worth of DYN shares. This transaction involved 934,581 shares at $10.70 per share.
Jason P. Rhodes currently owns 60,000 shares of Replimune Group, Inc. (REPL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jason P. Rhodes's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jason P. Rhodes has 180 Form 4 filings on record as an insider at Replimune Group, Inc..
Set alerts for Jason P. Rhodes and 40,000+ other insiders.